DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - BIT:CPR - NL0015435975 - Common Stock
5.488 EUR
-0.15 (-2.66%)
We assign a fundamental rating of 4 out of 10 to CPR. CPR was compared to 24 industry peers in the Beverages industry. Both the profitability and the financial health of CPR get a neutral evaluation. Nothing too spectacular is happening here. CPR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CPR was profitable.
In the past year CPR had a positive cash flow from operations.
In the past 5 years CPR has always been profitable.
Each year in the past 5 years CPR had a positive operating cash flow.
1.2 Ratios
CPR has a Return On Assets of 2.51%. This is in the lower half of the industry: CPR underperforms 62.50% of its industry peers.
Looking at the Return On Equity, with a value of 5.44%, CPR is doing worse than 70.83% of the companies in the same industry.
CPR's Return On Invested Capital of 7.03% is fine compared to the rest of the industry. CPR outperforms 62.50% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CPR is in line with the industry average of 7.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROIC | 7.03% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
Looking at the Profit Margin, with a value of 6.57%, CPR is in line with its industry, outperforming 41.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CPR has declined.
With a decent Operating Margin value of 21.32%, CPR is doing good in the industry, outperforming 62.50% of the companies in the same industry.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
With a decent Gross Margin value of 57.55%, CPR is doing good in the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
The number of shares outstanding for CPR has been increased compared to 1 year ago.
CPR has more shares outstanding than it did 5 years ago.
CPR has about the same debt/assets ratio as last year.
2.2 Solvency
CPR has an Altman-Z score of 2.54. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
CPR has a better Altman-Z score (2.54) than 70.83% of its industry peers.
The Debt to FCF ratio of CPR is 8.49, which is on the high side as it means it would take CPR, 8.49 years of fcf income to pay off all of its debts.
CPR has a Debt to FCF ratio of 8.49. This is comparable to the rest of the industry: CPR outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 0.64 indicates that CPR is somewhat dependend on debt financing.
CPR has a Debt to Equity ratio of 0.64. This is in the better half of the industry: CPR outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Altman-Z | 2.54 |
ROIC/WACC1.05
WACC6.68%
2.3 Liquidity
CPR has a Current Ratio of 2.32. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
CPR's Current ratio of 2.32 is amongst the best of the industry. CPR outperforms 87.50% of its industry peers.
A Quick Ratio of 0.91 indicates that CPR may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.91, CPR is doing good in the industry, outperforming 79.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
Measured over the past years, CPR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.12% on average per year.
The Revenue has been growing slightly by 5.18% in the past year.
The Revenue has been growing by 10.75% on average over the past years. This is quite good.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
3.2 Future
The Earnings Per Share is expected to grow by 11.73% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.72% on average over the next years.
EPS Next Y0.81%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
EPS Next 5Y11.73%
Revenue Next Year1.7%
Revenue Next 2Y2.14%
Revenue Next 3Y3.2%
Revenue Next 5Y4.72%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CPR is valuated quite expensively with a Price/Earnings ratio of 32.28.
Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 79.17% of the companies listed in the same industry.
CPR is valuated rather expensively when we compare the Price/Earnings ratio to 25.56, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 16.97, the valuation of CPR can be described as correct.
62.50% of the companies in the same industry are cheaper than CPR, based on the Price/Forward Earnings ratio.
CPR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.62.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.28 | ||
| Fwd PE | 16.97 |
4.2 Price Multiples
CPR's Enterprise Value to EBITDA ratio is in line with the industry average.
CPR's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.06 | ||
| EV/EBITDA | 11.48 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)39.87
PEG (5Y)N/A
EPS Next 2Y4.38%
EPS Next 3Y6.89%
5. Dividend
5.1 Amount
CPR has a Yearly Dividend Yield of 1.12%.
CPR's Dividend Yield is slightly below the industry average, which is at 3.16.
Compared to an average S&P500 Dividend Yield of 2.44, CPR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.69% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.69%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
BIT:CPR (11/18/2025, 5:36:15 PM)
5.488
-0.15 (-2.66%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners22.94%
Inst Owner ChangeN/A
Ins Owners51.06%
Ins Owner ChangeN/A
Market Cap6.76B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts71.54
Price Target6.88 (25.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.12% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.62%
PT rev (3m)-2.06%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.57%
EPS NY rev (3m)-0.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-1.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.28 | ||
| Fwd PE | 16.97 | ||
| P/S | 2.2 | ||
| P/FCF | 21.06 | ||
| P/OCF | 10.36 | ||
| P/B | 1.82 | ||
| P/tB | 55.66 | ||
| EV/EBITDA | 11.48 |
EPS(TTM)0.17
EY3.1%
EPS(NY)0.32
Fwd EY5.89%
FCF(TTM)0.26
FCFY4.75%
OCF(TTM)0.53
OCFY9.65%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)39.87
PEG (5Y)N/A
Graham Number3.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.51% | ||
| ROE | 5.44% | ||
| ROCE | 9.58% | ||
| ROIC | 7.03% | ||
| ROICexc | 7.57% | ||
| ROICexgc | 17.42% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 10.45% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 8.49 | ||
| Debt/EBITDA | 2.97 | ||
| Cap/Depr | 230.39% | ||
| Cap/Sales | 10.79% | ||
| Interest Coverage | 6.41 | ||
| Cash Conversion | 81.69% | ||
| Profit Quality | 159.18% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.54 |
F-Score6
WACC6.68%
ROIC/WACC1.05
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y0.81%
EPS Next 2Y4.38%
EPS Next 3Y6.89%
EPS Next 5Y11.73%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.7%
Revenue Next 2Y2.14%
Revenue Next 3Y3.2%
Revenue Next 5Y4.72%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year24.36%
EBIT Next 3Y12.31%
EBIT Next 5Y10.3%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%
DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.
What is the valuation status of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 5 / 10.
What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 32.28 and the Price/Book (PB) ratio is 1.82.
How sustainable is the dividend of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
The dividend rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 2 / 10 and the dividend payout ratio is 38.69%.